Article
Experience with lamivudine against hepatitis B virus.
Intervirology - 1 Jan 1997
Jaeckel E, Manns M P
Abstract excerpt
After several nucleoside analogues have been tested against chronic hepatitis B virus (HBV) infection with minimal success, lamivudine seems to be a highly effective new therapeutic option. This review focuses on nucleoside metabolism and on the molecular action of lamivudine as well as on results of clinical studies for several indications. We report on results of trials on the use of lamivudine for chronic HBV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
